Immix Biopharma | Investor Presentation Deck | 64 slides · page 20 of 64
The diagram shows a summation of ~29,712 (prevalence) and ~3,040 (derived from incidence) to reach ~32,752 eligible patients.
Deck · market_sizing · size_opportunity · balanced density
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 disclaimer 1/1 title 1/1
Components 3
process disclaimer headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1